Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$1.54 USD
0.00 (0.00%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $1.55 +0.01 (0.65%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (94 out of 251)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.56 | 9.99 |
Current Quarter Estimate | -0.57 | 0.26 | 61.00 |
Year Ago Quarter Estimate | -1.00 | -0.05 | 54.84 |
Next Quarter Estimate | -0.51 | -1.84 | 63.00 |
Next Year Estimate | -1.56 | 12.89 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 47.64 | 20.50 | 15.67 |
Next Year | 29.73 | 16.40 | 11.34 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.09 |
Price/Book (MRQ) | NA | 1.65 |
Price/Cash Flow (MRFY) | NA | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -240.15% | -58.89% |
Return on Equity (TTM) | -805.57% | -58.88% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.